Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ELAN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Timothy J. Bettington SEE REMARKS | ELAN Elanco Animal Health Incorporated | Sale | 4,350 | $23.00 | $100.0K Sale | Form 4 ↗ |
| Aug 20, 2026 | Lawrence Erik Kurzius Director | ELAN Elanco Animal Health Incorporated | Buy | 40,000 | $23.40 | $936.0K Buy | Form 4 ↗ |
| Aug 18, 2026 | Shiv O'Neill GC AND CORP SEC | ELAN Elanco Animal Health Incorporated | Buy | 3,998 | $23.58 | $94.3K Buy | Form 4 ↗ |
| Aug 12, 2026 | Michael J. Harrington Director | ELAN Elanco Animal Health Incorporated | Buy | 5,000 | $21.82 | $109.1K Buy | Form 4 ↗ |
| Aug 7, 2026 | Robert M. VanHimbergen EVP and CFO | ELAN Elanco Animal Health Incorporated | Buy | 4,200 | $23.08 | $96.9K Buy | Form 4 ↗ |
| Aug 7, 2026 | Paul Herendeen Director | ELAN Elanco Animal Health Incorporated | Buy | 10,000 | $23.69 | $236.9K Buy | Form 4 ↗ |
| May 15, 2026 | Rajeev A. Modi SEE REMARKS | ELAN Elanco Animal Health Incorporated | Buy | 4,911 | $20.35 | $99.9K Buy | Form 4 ↗ |
| May 15, 2026 | Jeffrey N. Simmons PRESIDENT, CEO AND DIRECTOR, Director | ELAN Elanco Animal Health Incorporated | Buy | 4,971 | $20.09 | $99.9K Buy | Form 4 ↗ |
| Dec 12, 2025 | Lawrence Erik Kurzius Director | ELAN Elanco Animal Health Incorporated | Buy | 10,000 | $21.30 | $213.0K Buy | Form 4 ↗ |
| Dec 11, 2025 | Rajeev A. Modi SEE REMARKS | ELAN Elanco Animal Health Incorporated | Buy | 4,500 | $21.33 | $96.0K Buy | Form 4 ↗ |
| Dec 11, 2025 | Robert M. VanHimbergen EVP and CFO | ELAN Elanco Animal Health Incorporated | Buy | 6,950 | $21.64 | $150.4K Buy | Form 4 ↗ |
| Dec 11, 2025 | Jeffrey N. Simmons PRESIDENT, CEO AND DIRECTOR, Director | ELAN Elanco Animal Health Incorporated | Buy | 22,000 | $21.75 | $478.5K Buy | Form 4 ↗ |
| Mar 11, 2025 | Lawrence Erik Kurzius Director | ELAN Elanco Animal Health Incorporated | Buy | 10,000 | $10.20 | $102.0K Buy | Form 4 ↗ |
| Mar 7, 2025 | Lawrence Erik Kurzius Director | ELAN Elanco Animal Health Incorporated | Buy | 10,000 | $10.90 | $109.0K Buy | Form 4 ↗ |
| Mar 5, 2025 | R. David Hoover Director | ELAN Elanco Animal Health Incorporated | Buy | 25,000 | $10.90 | $272.5K Buy | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances